Interestingly, bone marrow chimeras revealed that RIP1 activity was particularly important in bone marrow-derived macrophages, promoting the pathogenesis of experimental NASH by mediating inflammasome activation and cell death stimulation in macrophages. Here, RIPK1 is linked to metabolic dysfunction-associated steatohepatitis.